These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 839409)

  • 21. Modeling of drug release from bulk-degrading polymers.
    Lao LL; Peppas NA; Boey FY; Venkatraman SS
    Int J Pharm; 2011 Oct; 418(1):28-41. PubMed ID: 21182912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation.
    Dürig T; Fassihi R
    J Pharm Sci; 1997 Oct; 86(10):1092-8. PubMed ID: 9344163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theory of controlled release of biologically active substances.
    Collins RL; Doglia S
    Arch Environ Contam Toxicol; 1973 Dec; 1(4):325-46. PubMed ID: 4781317
    [No Abstract]   [Full Text] [Related]  

  • 25. A theoretical analysis of a new drug delivery system: a cylindrical device with a vertical opening on its surface.
    Hsu JP; Ting C; Lin MJ
    J Pharm Sci; 1992 Sep; 81(9):866-70. PubMed ID: 1432630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
    Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
    Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Floating-pulsatile release multiparticulate system for chronopharmacotherapy: effect of some hydrophobic additives on the buoyancy and release behavior of particles.
    Maghsoodi M
    Drug Res (Stuttg); 2014 Jan; 64(1):10-6. PubMed ID: 23950100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintaining a near zero-order drug delivery from minidose reservoirs: simultaneous drug diffusion and binary vehicle evaporation.
    Chen SX; Lostritto RT
    J Pharm Sci; 1997 Jun; 86(6):739-46. PubMed ID: 9188058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
    Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug release mechanisms of cast lipid implants.
    Kreye F; Siepmann F; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):394-400. PubMed ID: 21352913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow.
    Ali M; Horikawa S; Venkatesh S; Saha J; Hong JW; Byrne ME
    J Control Release; 2007 Dec; 124(3):154-62. PubMed ID: 17964678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of a peak-time criterion for designing controlled-release devices.
    Simon L; Ospina J
    Eur J Pharm Sci; 2016 Aug; 91():64-73. PubMed ID: 27260085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A general model of coupled drug release and tissue absorption for drug delivery devices.
    McGinty S; Pontrelli G
    J Control Release; 2015 Nov; 217():327-36. PubMed ID: 26390809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting.
    Zhang L; Alfano J; Race D; Davé RN
    Eur J Pharm Sci; 2018 May; 117():245-254. PubMed ID: 29499350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid and water-soluble polymer-based controlled release drug delivery system.
    Desai D; Kothari S; Chen W; Wang J; Huang M; Sharma L
    J Pharm Sci; 2011 May; 100(5):1900-12. PubMed ID: 21374622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MATHEMATICAL TREATMENT OF ORAL SUSTAINED RELEASE DRUG FORMULATIONS.
    ROWLAND M; BECKETT AH
    J Pharm Pharmacol; 1964 Dec; 16():SUPPL:156-62T. PubMed ID: 14265931
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro performance of floating sustained-release capsule of verapamil.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1067-72. PubMed ID: 9876561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
    Ghaly ES; Malavé MI; Rivera WJ; Martí A
    P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.